Journal of Autism and Developmental Disorders

, Volume 27, Issue 4, pp 479–489 | Cite as

Brief Report: Risperidone for Severely Disturbed Behavior and Tardive Dyskinesia in Developmentally Disabled Adults

  • Barkat U. Khan


Risperidone Tardive Dyskinesia Disturb Behavior Disable Adult 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Apter, A., Van Praag, H. M., Plutchik, R., Sevy, S., Korn, M., & Brown, S-L. (1990). Interrelationships among anxiety, aggression, impulsivity, and mood: A sertonergically linked cluster? Psychiatric Research, 32, 191–199.Google Scholar
  2. Brown, G. L., & Linnoila, M. I. (1990). CSDF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. Journal of Clinical Psychiatry, 51(Suppl. 4), 31–41.Google Scholar
  3. Campbell, J. J., & Duffy, J. D. (1995). Sertraline treatment of aggression in a developmentally disabled patient. Journal of Clinical Psychiatry, 56, 123–124.Google Scholar
  4. Casey, D. R., & Gerlach, J. (1986). Tardive dyskinesia: What is the longterm outcome? In D. E. Casey & G. Gardos (Eds.)., Tardive dyskinesia and neuroleptics: From dogma to reason (pp. 75–97). Washington, DC: American Psychiatric Press.Google Scholar
  5. Cavallero, R., Ragazetti, M. G., Mundo, E., Brancato, V., & Smeraldi, E. (1993). Tardive dyskinesia outcomes: Clinical and pharmacological correlates of remission and persistence. Neuropsychopharmacology, 8, 233–239.Google Scholar
  6. Chouinard, G. (1995). Effects of risperidone on tardive dyskinesia: An analysis of the Canadian multicenter risperidone study. Journal of Clinical Psychopharmacology, 15, 36S–44S.Google Scholar
  7. Chouinard, G., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclair, L., & Arnott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone had haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25–29.Google Scholar
  8. Czobor, P., Voklava, D., & Meiback, R. (1995). Effect of risperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology, 15, 243–249.Google Scholar
  9. Dalgalarrondo, P., & Gattaz, W. F. (1994). Basal ganglia abnormalities in tardive dyskinesia (TD). Possible relationship with duration of neuroleptic treatment. European Archives of Psychiatry and Clinical Neuroscience, 244, 272–277.Google Scholar
  10. Fuller, F. A. (1995). Influence of fluoxetine on aggressive behavior. Neuropsychopharmacology, 14, 77–81.Google Scholar
  11. Gardos, G., Casey, D. E., Cole, J. O., Perenyi, A., Kocsis, E., Arato, M., Samson, J. A., & Conley, C. (1994). Ten-year outcome of tardive dyskinesia. American Journal of Psychiatry, 151, 836–841.Google Scholar
  12. Glazer, W. M., & Morgenstern, H. (1988). Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population. Journal of Clinical Psychopharmacology, 8(Suppl.), 10S–16S.Google Scholar
  13. Golden, R. N., Gimore, J. H., Corrigan, M. H. N., Ekstrom, R. D., Knight, B. T., & Garbutt, J. C. (1991). Serotonin, suicide, and aggression: Clinical Studies. Journal of Clinical Psychiatry, 52(Suppl 12): 61–69.Google Scholar
  14. Jeanblanc, W., & Davis, Y. B. (1995). Risperidone for treating dementia-associated aggression. American Journal of Psychiatry, 152, 1239.Google Scholar
  15. Jeste, D. V., & Caligiuri, M. P. (1993). Tardive dyskinesia. Schizophrenia Bulletin, 19, 303–315.Google Scholar
  16. Khan, R. S., Van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988). Serotonin and anxiety revisited. Biological Psychiatry, 23, 189–208.Google Scholar
  17. Kane, J. M., Woerner, M., Borenstein, M., Wegner, J., & Lieberman, J. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254–258.Google Scholar
  18. Kopala, L. V., & Honer, W. G. (1994). Schizophrenia and tardive dyskinesia responsive to risperidone. Journal of Clinical Psychopharmacology, 14, 430–431.Google Scholar
  19. Kravitz, H. M., & Fawcett, J. (1994). Serenics for aggressive behavior. Psychiatric Annals, 24, 453–459.Google Scholar
  20. McDougle, C. J., Brodkin, E. S., Yeung, P. P., Naylor, S. T., Cohen, D. J., & Price, L. H. (1995). Journal of Child and Adolescent Psychopharmacology, 5, 273–282.Google Scholar
  21. Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825–834.Google Scholar
  22. Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. W. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400–405.Google Scholar
  23. Raheja, R. K., Bharwani, I., & Penetrante, A. E. (1995). Efficacy of risperidone for behavioral disorders in the elderly: A clinical observation. Journal of Geriatric Psychiatry and Neurology, 8, 159–161.Google Scholar
  24. Reid, A. H., & Ballinger, E. R. (1995). Behavioral symptoms among severely and profoundly mentally retarded patients. British Journal of Psychiatry, 167, 452–455.Google Scholar
  25. Shriqui, C., & Annable, L. (1995). Tardive dyskinesia. In C. L. Shriqui & H. A. Nasrallah (Eds.), Contemporary issues in the treatment of schizophrenia (pp. 585–632). Washington, DC: American Psychiatric Press.Google Scholar
  26. Shriqui, C., Nobecourt, P., Rousseau, F., & Arnott, W. (1994). Clinical efficacy of risperidone in a patient with severe tardive dyskinesia. Schizophrenia Research 11, 94 (Abstract).Google Scholar
  27. Simeon, J. G., Carrey, N. J., Wiggins, D. M., Milin, R. P., & Hosenbocus, S. N. (1995). Risperidone effects in treatment-resistant adolescents: Preliminary case reports. Journal of Child and Adolescent Psychopharmacology, 5, 69–79.Google Scholar
  28. Tamminga, C. A., Thaker, G. K., Moran, M., Kakigi, T., & Gao, X. M. (1994). Clozapine in tardive dyskinesia: Observations from human and animal model studies. Journal of Clinical Psychiatry, 55(Suppl.B), 102–106.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Barkat U. Khan
    • 1
  1. 1.Gulf Coast Center, FtMyers

Personalised recommendations